Drug
doravirine, lamivudine, and tenofovir disoproxil fumarate
Marketed as DELSTRIGO.
Generic name
doravirine, lamivudine, and tenofovir disoproxil fumarate
Brand names
DELSTRIGO
First FDA approval
2018-08-30
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| NDA210807 | DELSTRIGO | 2018-08-30 | MSD MERCK CO |
Manufacturers
MSD MERCK CO
Frequently asked questions
When was doravirine, lamivudine, and tenofovir disoproxil fumarate FDA approved?
Earliest FDA approval on record: 2018-08-30.
What brand names are sold as doravirine, lamivudine, and tenofovir disoproxil fumarate?
DELSTRIGO.
Sources
Appeal a doravirine, lamivudine, and tenofovir disoproxil fumarate denial
Upload the denial notice. DenialHelp helps verify the reason, organize source-linked evidence, and prepare a treating-clinician-reviewable package. Price and refund terms are shown before payment.
Get started →Contact: hello@denialhelp.com